Business

Companies
Markets
Property
Banking & Finance
Cryptocurrency
China EVs
Climate and energy
China Future Tech
Sovereign investment activity has become increasingly politicised, forcing some Western state-owned investors to avoid major deals in China, according to a data platform. Photo: EPA

Banking & Finance

Sovereign investors cut mainland China exposure as political sensitivities rise

Inflows fall 58 per cent as sovereign wealth funds grow cautious, yet outlook signals selective opportunities ahead, experts say.

China’s stock rally on AI optimism to stretch fundraising frenzy in 2026

Kuaishou taps global debt market with first US dollar, yuan bonds

Business

Hong Kong commercial property set for 10% rise in 2026, Colliers says

‘Measured recovery’ is in progress as mainland investment hits a half-decade high, consultancy says.

Workers clean the windows of a building in Tamar, with reflections of Wan Chai office towers reflected in the glass, on April 30, 2025. Photo: May Tse
Workers clean the windows of a building in Tamar, with reflections of Wan Chai office towers reflected in the glass, on April 30, 2025. Photo: May Tse

China Business

Hong Kong stocks advance as investors turn to China amid Middle East uncertainty

Hang Seng Index extends rally as regional markets find support amid rising tensions between the US and Iran.

Tech Trends

DeepSeek stays mum on next AI model release as technical papers show frontier innovation

Hangzhou-based start-up’s technical papers bode well for potential advances in its next major AI models.

Advertisement
Advertisement
Advertisement

China Business

Chinese solar firms eye price hikes amid silver surge, scrapping of tax rebate

China exported 206 gigawatts of photovoltaic modules in the first nine months of 2025, up 10 per cent from a year earlier.

Workers carry solar panels to install them at a solar farm in Lingwu, in China’s Ningxia Hui Autonomous Region, on April 14, 2025. Photo: China Daily via Reuters
Workers carry solar panels to install them at a solar farm in Lingwu, in China’s Ningxia Hui Autonomous Region, on April 14, 2025. Photo: China Daily via Reuters

Big Tech

Alibaba reaffirms open-source AI commitment as it hails successes

‘Building with the community’ is crucial to the success of the Qwen family of large language models, company says.

China Business

Chinese chain Qdama, known for its night discounts, plans Hong Kong IPO

The leading seller of meat and fresh produce on the mainland plans to open 1,400 stores in the next five years using proceeds from the IPO.

China Business

UBS projects rosy view of Chinese stocks in 2026 as investors diversify holdings

‘Chinese assets’ appeal will further increase this year because of a sharpened focus on diversified investments,’ UBS’ Thomas Fang says.

A Chinese trader looks at an electronic trading board at the Shanghai stock exchange. Photo: Reuters

China Business

Novartis, SciNeuro deal offers hope for 55 million suffering from Alzheimer’s

SciNeuro’s anti-amyloid programme is one of the firm’s key strategic research and development priorities to target the brain disease.

videocam
Swiss drugmaker Novartis has gained global rights over SciNeuro’s novel amyloid beta targeted antibody programme. Photo: Reuters
Swiss drugmaker Novartis has gained global rights over SciNeuro’s novel amyloid beta targeted antibody programme. Photo: Reuters

China Business

Johnnie Walker maker Diageo mulls options for China assets including sale: sources

Goldman Sachs and UBS are reviewing Diageo’s operations and are sounding out interest from local strategic buyers and private equity firms.

Banking & Finance

Chipmaker GigaDevice jumps 37% in Hong Kong debut amid China self-reliance push

GigaDevice shares surge as investors chase Beijing’s self-sufficiency theme, with retail demand oversubscribed more than 540 times.

Business

Expect no ‘systemic shock’ from Vanke’s ‘technical default’: HSBC

Even an ‘aggressive’ haircut would pose limited downside risks to key developers, bank says.

A security guard stands near a development by Vanke in Beijing on December 23, 2025. Photo: Reuters

Markets

Chinese rocket shares slump after warnings on ‘irrational’ rally

Long-term prospects for sector are ‘very promising’, but market in the short term is ‘mainly driven by speculative sentiment’, analyst says.

A rocket sits in the factory of Beijing Interstellar Glory Space Technology, a private rocket developer, in Wenchang, in south China’s Hainan province on December 30, 2025. Photo: Xinhua
A rocket sits in the factory of Beijing Interstellar Glory Space Technology, a private rocket developer, in Wenchang, in south China’s Hainan province on December 30, 2025. Photo: Xinhua

Business

Hong Kong stocks climb as yuan strengthens and investors broaden focus beyond US

Hang Seng Index advances as investors shift focus, boosting Asian equities, with pharmaceutical and healthcare shares leading gainers.

China Business

China’s weight-loss drug war: prices slashed up to 80% as obesity crisis worsens

Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 million in 2021.

Advertisement
Advertisement
Advertisement

Banking & Finance

What does HSBC’s buyout of Hang Seng Bank mean for its future and investors?

HSBC’s historic US$13.6 billion buyout of Hang Seng Bank aims to cut costs, tackle bad debts and fuel growth, but challenges abound.

Illustration by Henry Wong
Illustration by Henry Wong

Tech War

China takes confident strides to develop more AI innovation in 2026

‘China’s tech innovation is poised for policy-driven growth in 2026, with AI placed at the centre of the country’s economic agenda,’ NYU’s Winston Ma says.

China Business

From hope to hard numbers: China stocks will need profits to boost the bull run

Chinese shares surged in 2025 on a confidence-led re-rating – strategists now say the next leg in 2026 will hinge on an earnings uplift.

China Business

Are Chinese biotechs what the doctor ordered as Big Pharma faces ‘patent cliff’?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

US drugmakers are increasingly looking to Chinese biotechs as an answer to the revenue gaps left by the looming ‘patent cliff’. Illustration by Henry Wong
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
OPINION
Kun Tian

Opinion | Hong Kong’s fertile ground for AI IPOs aligns with China’s tech strategy

Kun Tian
Nicholas Spiro

Macroscope | What to expect from Chinese stocks in 2026

Nicholas Spiro
Nicholas Spiro

The View | How AI helped Asia’s real estate sector pass the tariff stress test

Nicholas Spiro
Jean Tirole

Opinion | To harness crypto ingenuity, financial threat must first be neutralised

Jean Tirole
Nicholas Spiro

Macroscope | Why Wall Street remains bullish on China amid economic slowdown

Nicholas Spiro
Hiba Malik

Opinion | How China is cementing its central role as the architect of green tech

Hiba Malik
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
MULTIMEDIA
Video

Pony.ai set to further open China’s autonomous-driving frontier

Pony.ai
07:39
Video

What’s behind HSBC’s privatisation of Hang Seng Bank?

HAng Seng
04:37
Video

Taiwan firm creates clothing from banana waste

Banana
01:00
Video

Gold scams in China and changing global politics

Wire
08:22
Advertisement
Advertisement
Advertisement
TRENDING TOPICS
Hong Kong stock exchange
IPO
China stock market
Belt and Road Initiative
China economy
Advertisement
Advertisement
Advertisement
MOST POPULAR
1

Foreign, Hong Kong retailers shut mainland China stores amid fierce competition

2

Changing tastes: China’s new affluent consumers seek quality not extravagance

3

What does HSBC’s buyout of Hang Seng Bank mean for its future and investors?

4

Chinese biotechs strike a record US$136 billion in out-licensing deals in 2025

5

Hang Seng Bank shareholders approve HSBC’s US$14 billion buyout plan